Vanderbilt researchers created the first selective compound designed to inhibit TAOK-1, a poorly understood protein connected to Alzheimer’s disease. They also discovered a second compound that activates the entire TAOK protein family, offering scientists an unexpected new research tool.
All Top News -- ScienceDaily reports that vanderbilt researchers created the first selective compound designed to inhibit TAOK-1, a poorly understood protein connected to Alzheimer’s disease.
The report adds: They also discovered a second compound that activates the entire TAOK protein family, offering scientists an unexpected new research tool.
Together, the compounds could reveal hidden disease mechanisms and point toward new treatment strategies.
This report is covered across the current DAMMNEWS feeds. Health reports can affect personal decisions, so the source, study size and official guidance matter more than a short headline alone.
This is a developing report. DAMMNEWS will surface related coverage as closely matched reporting enters the live cache.
DAMMNEWS RSS BRIEFING — generated locally from the available All Top News -- ScienceDaily headline and RSS excerpt. It is not a summary of the full source article.